feed,title,long_url,short_url
Benzinga,"After Blood Cancer, Pfizer Now Bolsters Its Inflammatory Diseases Pipeline With $6.7B Arena Deal",https://benzinga.com/general/biotech/21/12/24567171/after-blood-cancer-pfizer-now-bolsters-its-inflammatory-diseases-pipeline-with-6-7b-arena-deal,https://j.mp/3F2S0Xa
